By InvitationNot Applicable

Expert Consensus on the Use of Isotretinoin in Acne Vulgaris: A Delphi Study

Egypt15 participantsStarted 2026-01-25

Plain-language summary

This study is a Delphi-based expert consensus project designed to establish evidence-informed, practical recommendations for the use of isotretinoin in acne vulgaris. Despite isotretinoin being the most effective therapy for severe and refractory acne, variations persist in its indications, dosing strategies, monitoring protocols, and safety counseling.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Board-certified or equivalent dermatologist, Minimum of 5 years of post-certification clinical experience in the management of acne vulgaris, Regular prescribing experience with oral isotretinoin in routine clinical practice, Willingness to participate in all Delphi rounds. Exclusion Criteria: * Inability or unwillingness to complete Delphi rounds.• Lack of clinical experience with isotretinoin.• Industry representatives without direct clinical practice

What they're measuring

Primary Outcome

Timeframe: 6-12 weeks

Trial details

NCT IDNCT07296523

SponsorVenus Research Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-06-01

View on ClinicalTrials.gov More Isotretinoin trials